Allurion
OTC: ALURDNatick, US · Founded 2023 · Delaware corporation · 118 employees on LinkedIn · 5 known investors
Allurion offers a weight-loss program built around a swallowable, procedureless gastric balloon combined with nutrition coaching, connected digital tools, and AI-driven clinician support. It serves patients seeking non-surgical obesity treatment and works through a network of accredited clinics.
Founders & leadership
Allurion was founded in 2023 by Shantanu Gaur and Samuel Levy.
SG
Shantanu GaurinCo-founderCo-founder of Allurion, which develops a weight-loss platform built around a swallowable gastric balloon along with a virtual care suite, a behavior-change program, and an AI platform for people who are overweight or living with obesity.
SL
Samuel LevyCo-founder
BG
Brendan GibbonsExecutive
OB
Ojas BuchinExecutive
RC
Ram ChuttaniExecutive
JD
Jonathan D WeckerExecutive
BJ
Benoit Jacques Claude ChardonExecutive
CG
Chris GeberthExecutive
DH
Douglas Hudson LarsonNamed on SEC filing
Board
NL
Nicholas LewinBoard director
KG
NC
Investors · 5
Reported raises · per SEC filings
Form D private placements$33.2M disclosed across 5 rounds · 2014–2025
▶$5MraisedNov 2025 · 16 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2025 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ram ChuttaniExecutive Officer
- Keith JohnsDirector
- Omar IshrakDirector
- Brendan GibbonsExecutive Officer
- Michael DavinDirector
- R. Jason RicheyDirector
- Shantanu GaurExecutive Officer, Director
- Nicholas LewinDirector
- Larson Douglas HudsonDirector
- Ojas BuchExecutive Officer
- Krishna GuptaDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $350K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$7.4MraisedFeb 2025 · 14 investors · Other Health CareRule 506(b)
▶$7.4MraisedFeb 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Milena Alberti-PerezDirector
- Brendan GibbonsExecutive Officer
- Ojas BuchExecutive Officer
- Ram ChuttaniExecutive Officer
- Nicholas LewinDirector
- Keith JohnsDirector
- Michael DavinDirector
- Omar IshrakDirector
- Larson Douglas HudsonDirector
- Krishna GuptaDirector
- Shantanu GaurExecutive Officer, Director
- R. Jason RicheyDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- Sales commissions
- $520.8K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$122.5KraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$122.5KraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Benoit Jacques Claude ChardonExecutive Officer
- Shantanu GaurExecutive Officer, Director
- Nicholas LewinDirector
- Douglas Hudson LarsonDirector
- Omar IshrakDirector
- Ram ChuttaniExecutive Officer
- Chris GeberthExecutive Officer
- Krishna GuptaDirector
- Michael DavinDirector
- Offering amount
- $100.1M
- Amount sold
- $122.5K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$19MraisedFeb 2017 · 45 investors · Other Health CareRule 506(b)
▶$19MraisedFeb 2017 · 45 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Krishna GuptaDirector
- Jonathan D WeckerExecutive Officer, Director
- Shantanu K GaurExecutive Officer, Director
- Samuel G LevyExecutive Officer, Director
- Neil ChhedaDirector
- Offering amount
- $27.3M
- Amount sold
- $19M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJul 2014 · 21 investors · Other Health CareRule 506(b)
▶$1.6MraisedJul 2014 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Samuel G LevyExecutive Officer, Director
- Shantanu K GaurExecutive Officer, Director
- Jonathan D WeckerExecutive Officer, Director
- Amount sold
- $1.6M
- Proceeds to insiders
- $528K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Allurion for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Allurion do?
- Allurion offers a weight-loss program built around a swallowable, procedureless gastric balloon combined with nutrition coaching, connected digital tools, and AI-driven clinician support. It serves patients seeking non-surgical obesity treatment and works through a network of accredited clinics.
- Who founded Allurion?
- Allurion was founded by Shantanu Gaur, Samuel Levy in 2023.
- Who are Allurion's investors?
- Allurion's investors include Kube VC, REMUS Capital, Runway Growth Capital, CPH Capital, Romulus Capital.
- How much funding has Allurion raised?
- Allurion has disclosed $33.2M raised across 5 rounds.
- Where is Allurion headquartered?
- Allurion is headquartered in Natick, US.